Interaction of morphine and haloperidol on agonistic and motor behaviors of male mice

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 1, 1997, Pages 153-158

  Rodríguez Arias, Marta ^a   Miñarro, José ^a   Simón, Vicente M ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Aggression; Haloperidol; Mice dopamine; Morphine; Motor activity; Opiates; reward

Indexed keywords

HALOPERIDOL; MORPHINE; NEUROLEPTIC AGENT;

AGGRESSION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

AGONISTIC BEHAVIOR; ANALGESICS, OPIOID; ANIMALS; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; EXPLORATORY BEHAVIOR; GROOMING; HALOPERIDOL; MALE; MICE; MICE, INBRED STRAINS; MORPHINE; MOTOR ACTIVITY; SOCIAL BEHAVIOR;

ANIMALIA;

EID: 0343632344     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00403-0     Document Type: Article

References (48)

1. Acquas E., Carboni E., Leone P., Di Chiara G. SCH23390 blocks drug-conditioned place-preference and place-aversion. Anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade Psychopharmacology. 99:1989;151-155.
2. Aguilar M. A., Miñarro J., Pérez-Iranzo N., Simón V. M. Behavioral profile of raclopride in agonistic encounters between male mice. Pharmacol. Biochem. Behav. 47:1994;753-756.
3. Axon D. I. R., Fletcher G. H., Starr M. S. In morphinised rats SKF 38393 converts dopamine D2 receptor-mediated forward locomotion into backward walking. Pharmacol. Biochem. Behav. 26:1987;45-47.
4. Balsara J. J., Nandal N. V., Burte N. P., Jadhav J. H., Chandorkar A. G. Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats. Psychopharmacology. 82:1984;237-240.
5. Bozarth M. A. Opioid reinforcement processes. Rodgers R. J., Cooper S. J. Endorphins, opiates and behavioural processes. 1988;53-75 John Wiley and Sons Ltd, London.
6. Bozarth M. A., Wise R. A. Neural substrates of opiate reinforcement. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 7:1983;569-575.
7. Brain P. F., Benton D., Childs G., Parmigiani S. The effect of the opponent in test of murine aggression. Behav. Processes. 6:1981;319-328.
8. Brain P. F., McAllister K. H., Wamsley S. V. Drug effects on social behaviour. Methods in ethopharmacology. In: Boulton A. A., Baker G. B., Greenshow A. J. Neuromethods. 1989;687-739 The Humana Press Inc, Clifton, NJ.
9. Cambell A., Baldessarini R. J. Circadian changes in behavioral effects of haloperidol in rats. Psychopharmacology. 77:1982;150-155.
10. Cooper S. J. Interactions between endogenous opioids and dopamine. Implications for reward and aversion Willner P., Scheel-Kruger J. The mesolimbic dopamine system. From motivation to action:1991;331-366 John Wiley & Sons Ltd, London.
11. Cunningham S. T., Kelley A. E. Opiate infusion into nucleus accumbens. Contrasting effects on motor activity and responding for conditioned reward Brain Res. 588:1992;104-114.
12. Da Silva Planeta C., Luiz M., DeLucia R. Reinforcing properties of fencamfamine. Involvement of dopamine and opioid receptors Pharmacol. Biochem. Behav. 50:1994;35-40.
13. Di Chiara G., Imperato A. Opposite effects of mu and kappa opiate agonist on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
14. Espert R., Navarro J. F., Salvador A., Simón V. M. Effects of morphine hydrochloride on social encounters between male mice. Aggressive Behav. 19:1993;377-383.
15. Gianutsos G., Lal H. Narcotic analgesis and aggression. Mod. Probl. Pharmacopsychiatry. 13:1978;114-138.
16. Gerrits M. A., Ramsey N. F., Wolterink G., Van Rees J. M. Lack of evidence for an involvement of nucleus accumbens dopamine D1 receptors in the initiation of heroin self-administration in the rat. Psychopharmacology. 114:1994;486-494.
17. Iwamoto E. Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat. Influence of dopaminergic agonists and antagonists J. Pharmacol. Exp. Ther. 217:1981;451-460.
18. Johnson S. W., North R. A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12:1992;483-488.
19. Joyce E. M., Iversen S. D. The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat. Neurosci. Lett. 14:1979;207-212.
20. Joyce E. M., Koob G. F., Strecker R., Iversen S. D., Bloom F. The behavioral effects of enkephalin analogues injected into the ventral tegmental area and globus pallidus. Brain Res. 221:1981;359-370.
21. Kalivas P. W., Widerlow E., Stanley D., Breese G., Prange A. J. Jr. Enkephalin action on the mesolimbic system. A dopamine-dependent and a dopamine-independent increase in locomotor activity J. Pharmacol. Exp. Ther. 227(10):1983;229-237.
22. Kantak K. M., Miczek K. Social, motor and autonomic signs of morphine withdrawal. Differential sensitivities to catecholaminergic drugs Psychopharmacology. 96:1988;468-476.
23. Kiritsy-Roy J. A., Standish S. M., Cass Tery L. Dopamine D1 and D2 receptor antagonists potentiate analgesic and motor effects of morphine. Pharmacol. Biochem. Behav. 32:1989;717-721.
24. Lal H., Gianutsos G., Puri S. K. A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity. Life Sci. 17:1975;29-34.
25. Layer R. T., Uretsky N. J., Wallace L. J. Effects of morphine in the nucleus accumbens on stimulant-induced locomotion. Pharmacol. Biochem. Behav. 40:1991;21-26.
26. Longoni R., Spina L., Di Chiara G. Dopaminergic D1 receptors. Essential role in morphine-induced hypermotility Psychopharmacology. 93:1987;401-402.
27. Magnus-Ellenbroek B., Haverman-Reinecke U. Morphine-induced hyperactivity in rats, a rebound effect? Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;635-642.
28. Martínez M., Miñarro J., Simón V. M. Análisis etoexperimental de la conducta agonística en ratones macho. Psicológica. 12:1991;1-22.
29. Miñarro J., Castaño D., Brain P. F., Simón V. M. Haloperidol does not antagonize the effects of stress on aggressive behavior in mice. Physiol. Behav. 47:1990;281-287.
30. Navarro J. F., Miñarro J., Simón V. M. Antiaggressive and motor effects of haloperidol show different temporal patterns in the development of tolerance. Physiol. Behav. 53:1993;1055-1059.
31. Olson G., Olson R., Kastin A. Endogenous opiates. 1990 Peptides. 12:1991;1407-1432.
32. Potegal M. The reinforcing value of several types of aggressive behavior. A review Aggressive Behav. 5:1979;353-373.
33. Redolat R., Miñarro J., Simón V. M., Brain P. F. Influences of haloperidol and sulpiride on social behavior of female mice in interactions with anosmic males. Psicothema. 3(1):1991;79-85.
34. Self D., Nestler E. J. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18:1995;463-495.
35. Shippenberg T. S., Bals-Kubick R., Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids. Role of the mesolimbic dopamine system and D1 versus D2 dopamine receptors J. Pharmacol. Exp. Ther. 265:1993;53-59.
36. Shippenberg T. S., Herz A. Motivational effects of opioids. Influence of D1 versus D2 receptors antagonists Eur. J. Pharmacol. 151:1988;233-242.
37. Smoothy R., Brain P. F., Berry M. S., Haug M. Alcohol and social behaviour in group-housed female mice. Physiol. Behav. 37:1986;689-694.
38. Spanagel R., Herz A., Bals-Kubik R., Shippenberg T. β-Endorphin induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology. 104:1991;51-56.
39. Spanagel R., Shoaib M. Involvement of mesolimbic κ-opioid systems in the discriminative stimulus effects of morphine. Neuroscience. 63:1994;797-804.
40. Spyraki C., Fibiger H. C., Phillips A. G. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology. 79:1983;278-283.
41. Stinus L., Cador M., Le Moal M. Interaction between endogenous opioids and dopamine within the nucleus accumbens. Ann. N.Y. Acad. Sci. 654:1992;254-273.
42. Stinus L., Koob G., Ling N., Bloom F., LeMoal M. Locomotor activation induced by infusion of endorphins into the ventral tegmental area. Evidence for opiate-dopamine interactions Proc. Natl. Acad. Sci. USA. 77:1980;2323-2327.
43. Stinus L., Nadaud D., Deminiére J., Jauregui J., Hand T., Le Moal M. Chronic flupenthixol treatment potentiates the reinforcing properties of systemic heroin administration. Biol. Psychiatry. 26:1989;363-371.
44. Tidey J. W., Miczek K. A. Morphine withdrawal aggression. Modifications with D1 and D2 receptor agonists Psychopharmacology. 108:1992;177-184.
45. Vaccarino F. J., Amalric M., Swerlow N. R., Koob G. Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat. Pharmacol. Biochem. Behav. 24:1986;61-65.
46. Vermeulen R. J., Drukarch B., Rob Sahadat M. C., Goosen C., Schoffelmeer A. N. M., Wolters E. C., Stoof J. C. Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys. Psychopharmacology. 118:1995;451-459.
47. Winslow J. T., Miczek K. A. Naltrexone blocks amphetamine-induced hyperactivity but not disruption of social and agonistic behavior in mice and squirrel monkeys. Psychopharmacology. 96:1988;493-499.
48. Wise R. A., Rompre P. P. Brain dopamine and reward. Annu. Rev. Psychol. 40:1989;191-225.